Oncolytics Biotech (ONCY) Revenue (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Revenue came in at -$74088.4 in Q3 2025, down 473.46% year-on-year from $19838.6 in Q3 2024, and down 473.46% on a QoQ basis from $19838.6 in Q3 2024.
Oncolytics Biotech (ONCY) Revenue (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 10 years of Revenue data on file, last reported at -$74088.4 in Q3 2025.
- On a quarterly basis, Revenue fell 473.46% year-over-year to -$74088.4 in Q3 2025; TTM through Sep 2025 was $65.8 million, a 34.48% decrease from a year earlier, with the FY2018 full-year figure at $13.7 million, changed N/A from the prior year.
- Revenue for Q3 2025 stood at -$74088.4, down from $19838.6 in the prior quarter.
- Over the last five years, Revenue for ONCY reached as high as $19838.6 in Q3 2024 and fell as low as -$74088.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -74,088.43 |
| Sep 30, 2024 | 19,838.62 |
| Sep 30, 2020 | 31.24 Mn |
| Jun 30, 2020 | 34.60 Mn |
| Mar 31, 2020 | 34.55 Mn |
| Sep 30, 2019 | 12.30 Mn |
| Jun 30, 2019 | 12.28 Mn |
| Mar 31, 2019 | 14,214.00 Bn |
| Dec 31, 2018 | 13.70 Mn |
| Sep 30, 2018 | 16,214.00 |
| Jun 30, 2017 | 570.03 Bn |
| Jun 30, 2016 | 710,374.00 |
| Jun 30, 2011 | 1.39 Mn |
| Sep 30, 2010 | 310,000.00 |
| Jun 30, 2010 | 635,338.00 |
| Dec 31, 2009 | 310,000.00 |
| Sep 30, 2009 | 9.66 Mn |
| Jun 30, 2009 | 11.98 Mn |
| Mar 31, 2009 | 9.29 Mn |